DHR · NYSE · CIK 0000313616
Danaher Corporation
No equity stake in another company appears in Danaher Corporation's filings. That is the sourced answer, not a hole in the research.
Share price
DHR
Who owns Danaher Corporation.
sized by
modelled, reported or pending
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 2,133 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
2,133 managers reported a position, together holding 571.2m shares, or 81.3% of the company. The 40 largest are listed.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- Danaher does not file Form 13F under CIK 0000313616. The EDGAR submissions JSON for this CIK (checked 17 August 2026, 1,005 recent filings scanned) contains no 13F-HR or 13F-NT of any vintage, consistent with Danaher being an operating company rather than an institutional investment manager.
- Spin-off question resolved: Danaher retains no residual listed stake in any of its three spin-offs. The FY2025 Form 10-K (filed 24 Feb 2026) states that Fortive Corporation (2016), Envista Holdings Corporation (2019) and Veralto Corporation (2023) were each separated 'by distributing to Danaher stockholders on a pro rata basis all of the issued and outstanding common stock' of the respective entity, i.e. full distributions with nothing retained by Danaher itself. Confirming this, neither the FY2025 10-K nor the Q2 FY2026 10-Q (period ended 26 Jun 2026, filed 21 Jul 2026) mentions Envista, Veralto or Fortive anywhere outside the tax-risk-factor paragraph about the separations' tax treatment; there is no equity-securities, equity-method or retained-interest line item naming any of the three.
- The holdings list is empty and that is the sourced finding, not a gap. The FY2025 10-K and the Q2 FY2026 10-Q were searched for 'equity method', 'investments in unconsolidated', 'non-marketable', 'measurement alternative', 'retained interest', 'Envista', 'Fortive', 'Veralto', and 'strategic investment'. Danaher discloses only combined balances: 'investments in equity securities' of $217 million (Q2 FY2026) / $165 million publicly traded plus non-marketable at fair value under the measurement alternative ($218 million total per the FY2025 10-K's Level 1/Level 3 fair value table), and a separate $1.4 billion carrying value (unchanged between 31 Dec 2025 and 31 Dec 2024) of 'equity method investments... in partnerships' where Danaher is a limited partner investing in start-up companies. In 2025 Danaher invested $127 million and received $12 million from sales of non-marketable equity securities and partnerships. No individual investee, portfolio company or partnership name, ownership percentage, or per-position carrying value is disclosed anywhere in either filing, so per the brief every affected holding is null; the combined figures are recorded here instead rather than assigned to any one investee.
- Danaher has a single class of common stock, $0.01 par value, one vote per share. There is no dual-class structure, but the Rales brothers' combined economic and voting stake (Steven M. Rales, 5.97%, plus Mitchell P. Rales, 4.66%, totaling roughly 10.6% of shares outstanding, per the 2026 proxy) is the company's founder-control story; the proxy itself states Steven Rales 'owns approximately 6% of the Company's outstanding shares' and cites this as the board's rationale for keeping the Chairman and CEO roles separate.
- Rales rows, decided per the proxy's own footnotes: each brother's reported beneficial-ownership figure in the DEF 14A ALREADY includes shares held by LLCs of which a revocable trust he controls is the sole member, plus 401(k), deferred-compensation, and charitable-foundation shares (foundation shares are held despite a formal disclaimer of beneficial ownership, but the proxy still counts them in the reported total). No separate rows were created for the family LLCs, trusts, or foundations; doing so would double count against the already-inclusive per-person totals. Both Rales rows are marked rolls_up_into the 'All current executive officers and directors as a group (21 persons)' row, which itself is marked is_aggregate. Arithmetic check: Steven Rales (42,240,297) + Mitchell Rales (33,001,391) + Rainer Blair (569,014) = 75,810,702, which is less than the group's reported 76,782,313, consistent with the invariant that named members must sum to no more than the aggregate.
- Denominators used, kept apart per the brief: the 30 Jun 2026 13F rows (BlackRock, State Street, Geode, Morgan Stanley, JPMorgan, FMR) use 702,986,054 shares outstanding, from the Q2 FY2026 10-Q cover page (number of shares outstanding at 16 Jul 2026). The Vanguard row is for the quarter ended 31 Dec 2025 (Vanguard filed Form 13F-NT, notice only, for the two most recent quarters) and uses 707,139,356 shares outstanding from the FY2025 10-K cover page (as of 2 Feb 2026). The Rales, Blair, and officers-group rows use the 2026 DEF 14A's own count of 707,699,419 shares outstanding as of the proxy record date, with beneficial ownership stated 'as of March 1, 2026' in the table itself.
- Proxy cross-checks and one disagreement: Danaher's 2026 DEF 14A's own 5%-holder table cites a Vanguard Schedule 13G (filed 30 Jan 2026, as of 31 Dec 2025) showing 60,973,344 shares (8.6%), which is within 5,016 shares of Vanguard's own 13F-HR figure used in the register, consistent. The proxy's cited BlackRock Schedule 13G figure (50,771,463 shares, 7.2%, as of 31 Dec 2023) is stale relative to BlackRock's own 30 Jun 2026 Form 13F-HR (55,084,630 shares) used in the register instead; both figures are recorded here for transparency.
- Market capitalisation of $142.32 billion is the figure published by stockanalysis.com as of 14 August 2026, at a closing price of $202.45. Cross-check: 702,986,054 shares x $202.45 implies approximately $142.3 billion, consistent.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- No individual investee, portfolio company, or partnership name behind Danaher's combined $1.4 billion equity-method partnership carrying value or its $165-218 million publicly traded plus non-marketable equity securities balance. Searched the FY2025 10-K's fair value measurement note (Note 11) and MD&A investment-activity discussion, and the Q2 FY2026 10-Q's equivalent fair value note, for 'equity method', 'non-marketable', 'measurement alternative', 'venture capital', 'strategic investment', 'Envista', 'Veralto', 'Fortive', 'retained interest'. None names a counterparty.
- Whether Danaher holds any small residual consideration (e.g. contingent payments, earnout shares) tied to the Envista (2019), Fortive (2016) or Veralto (2023) separations. Both the FY2025 10-K and Q2 FY2026 10-Q are silent on this beyond the tax-indemnification risk factor; no retained-interest or receivable line item tied to any of the three was found.
- Sovereign wealth fund holdings (e.g. Norges Bank, GIC). Not sourced within the time budget; sovereign funds typically hold DHR through index mandates and mostly do not file Form 13F.
- Capital Group, T. Rowe Price, and other large active managers' 13F positions were not pulled individually; only the seven managers named in the brief's useful-CIK list (Vanguard, BlackRock, State Street, Geode, FMR, Morgan Stanley, JPMorgan) plus the proxy's Rales, CEO, and officers-group rows were used for the register.
- Danaher's Q3 FY2026 10-Q (period ending on or about 30 Sep 2026) had not yet been filed as of 17 August 2026, so any equity investment activity in that quarter is not reflected here.
- Whether any of the historical Schedule 13D/13D-A filings on Danaher's own CIK (multiple filed 2020-2021, entity names not individually resolved within the time budget) relate to Rales-controlled entities beyond what the 2026 proxy already discloses was not investigated further; the proxy's own beneficial-ownership table and footnotes were treated as the authoritative, most current source for the Rales positions instead.
